Collectively, the crosstalk between ILC3s and KCs plays an important role in inflammatory skin disorders like psoriasis and atopic dermatitis, thus providing an unprecedented opportunity to therapeutically target or harness the interactions to treat these diseases (Fig. 1b). This evidence concerns the gene TBCE and atopic eczema.